Target Healthcare REIT Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Target Healthcare REIT wird ein Gewinn- und Umsatzwachstum von 7.7% bzw. 4.1% pro Jahr prognostiziert, während der Gewinn pro Aktie um 5.7% pro Jahr wachsen soll.

Wichtige Informationen

7.7%

Wachstumsrate der Gewinne

5.7%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum	30.3%
Wachstumsrate der Einnahmen	4.1%
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	Low
Zuletzt aktualisiert	27 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

Gewinn- und Umsatzwachstumsprognosen

BATS-CHIXE:THRLL - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (GBP Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2026	75	71	N/A	52	3
6/30/2025	73	70	N/A	50	3
6/30/2024	70	63	N/A	52	3
12/31/2023	68	58	37	37	N/A
9/30/2023	68	26	33	33	N/A
6/30/2023	68	-7	30	30	N/A
3/31/2023	70	-5	37	37	N/A
12/31/2022	71	-4	45	45	N/A
9/30/2022	68	23	38	38	N/A
6/30/2022	64	49	30	30	N/A
3/31/2022	58	48	22	22	N/A
12/31/2021	52	47	13	13	N/A
9/30/2021	51	45	19	19	N/A
6/30/2021	50	44	25	25	N/A
3/31/2021	49	37	31	31	N/A
12/31/2020	48	31	37	37	N/A
9/30/2020	46	31	29	29	N/A
6/30/2020	44	32	21	21	N/A
3/31/2020	42	32	15	15	N/A
12/31/2019	39	31	8	8	N/A
9/30/2019	37	31	13	13	N/A
6/30/2019	34	30	18	18	N/A
3/31/2019	32	29	15	15	N/A
12/31/2018	31	28	12	12	N/A
9/30/2018	30	28	17	17	N/A
6/30/2018	28	28	22	22	N/A
3/31/2018	27	25	19	19	N/A
12/31/2017	26	22	16	16	N/A
9/30/2017	25	21	N/A	9	N/A
6/30/2017	23	19	N/A	3	N/A
3/31/2017	21	17	N/A	6	N/A
12/31/2016	20	14	N/A	9	N/A
9/30/2016	18	13	N/A	9	N/A
6/30/2016	17	12	N/A	9	N/A
3/31/2016	16	13	N/A	8	N/A
12/31/2015	15	15	N/A	8	N/A
9/30/2015	14	12	N/A	8	N/A
6/30/2015	14	10	N/A	8	N/A
12/31/2014	9	3	N/A	7	N/A
9/30/2014	7	2	N/A	5	N/A
6/30/2014	4	1	N/A	3	N/A
12/31/2013	3	-1	N/A	3	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: THRLLDas prognostizierte Gewinnwachstum (7.7% pro Jahr) liegt über der Sparquote (1.8%).

Ertrag vs. Markt: THRLLDie Erträge des Unternehmens (7.7% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt UK (13.1% pro Jahr).

Hohe Wachstumserträge: THRLLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: THRLLDie Einnahmen des Unternehmens (4.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt UK (3.6% pro Jahr).

Hohe Wachstumseinnahmen: THRLLDie Einnahmen des Unternehmens (4.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von THRLL in 3 Jahren voraussichtlich hoch sein wird

Target Healthcare REIT Zukünftiges Wachstum

Future Kriterienprüfungen 2/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

An undisclosed buyer acquired Four UK care homes from Target Healthcare REIT PLC (LSE:THRL) for £44.5 million.

Now 20% overvalued after recent price rise

Dividend of UK£0.014 announced

Target Healthcare REIT PLC Declares Third Interim Dividend for the Period from 1 January 2024 to 31 March 2024, Payable on 31 May 2024

First half 2024 earnings released: EPS: UK£0.05 (vs UK£0.055 loss in 1H 2023)

Target Healthcare REIT PLC to Report First Half, 2024 Results on Mar 12, 2024

Fourth quarter dividend of UK£0.014 announced

Now 22% undervalued

Target Healthcare Reit plc Declares Second Interim Dividend for the Period from 1 October 2023 to 31 December 2023, Payable on 23 February 2024

Now 20% undervalued

Now 20% undervalued

Now 20% undervalued

Target Healthcare REIT PLC Declares First Interim Dividend for the Period from 1 July 2023 to 30 September 2023, Payable on 24 November 2023

Full year 2023 earnings released: UK£0.011 loss per share (vs UK£0.082 profit in FY 2022)

Target Healthcare REIT PLC to Report Fiscal Year 2023 Results on Oct 10, 2023

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2023, Payable on August 25, 2023

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2023, Payable on 26 May 2023

First half 2023 earnings released: UK£0.055 loss per share (vs UK£0.032 profit in 1H 2022)

Now 21% undervalued after recent price drop

Target Healthcare REIT PLC Announces Second Interim Dividend for the Year Ending 30 June 2023, Payable on 24 February 2023

High number of new and inexperienced directors

Now 21% undervalued after recent price drop

Now 21% undervalued after recent price drop

High number of new and inexperienced directors

Target Healthcare REIT PLC Appoints Michael Brodtman as an Independent Non-Executive Director, Effective 1 January 2023

Target Healthcare REIT PLC, Annual General Meeting, Dec 06, 2022

Now 20% undervalued after recent price drop

Target Healthcare REIT PLC Announces First Interim Dividend for the Period ended September 30, 2022, Payable on 25 November 2022

Full year 2022 earnings released: EPS: UK£0.082 (vs UK£0.092 in FY 2021)

Target Healthcare REIT plc Announces Board Changes

Target Healthcare REIT PLC Declares Fourth Interim Dividend for the Year Ended 30 June 2022, Payable on August 26, 2022

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2022, payable on 27 May 2022

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Announces Appointment of Amanda Thompsell as an Independent Non-Executive Director

Target Healthcare REIT PLC (LSE:THRL) acquired Portfolio of 18 operational modern care homes in Weymouth.

Full year 2021 earnings released: EPS UK£0.092 (vs UK£0.072 in FY 2020)

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £125 million.

Target Healthcare REIT PLC (LSE:THRL) acquired Luxury Care Home in Scotland and a Development site in Buckinghamshire for £33 million.

Upcoming dividend of UK£0.017 per share

Target Healthcare REIT PLC Declares Third Interim Dividend for the Year Ending 30 June 2021, Payable on 28 May 2021

First half 2021 earnings released: EPS UK£0.035 (vs UK£0.039 in 1H 2020)

Target Healthcare REIT PLC has completed a Follow-on Equity Offering in the amount of £60 million.

New 90-day low: UK£1.11

Target Healthcare REIT PLC (LSE:THRL) acquired Development site in Droitwich Spa.

New 90-day high: UK£1.18

Target Healthcare REIT PLC to Report Fiscal Year 2020 Results on Oct 06, 2020

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken